Hi, you are logged in as , if you are not , please click here
You are shopping as , if this is not your email, please click here

Cancer Research UK & UCL Cancer Trials Centre (H01)

Cancer Inst

The Cancer Research UK and UCL Cancer Trials Centre (CTC) is one of the largest dedicated cancer trials units in the UK. It was formed in 1997, and is now a research department within the UCL Cancer Institute. The CTC develops and conducts high quality studies to find new ways of treating or detecting cancer, and understanding mechanisms of how cancer develops. It has established collaborations with clinicians and scientists, nationally and internationally, to generate new scientific research proposals, develop laboratory projects associated with CTC studies, and train a new generation of clinical trials specialists.

Studies are conducted in a wide range of tumours, primarily, lung, lymphoma, gastrointestinal, head and neck, gynaecology, brain, and sarcoma. Cancer Research UK provides the main source of core funding, with additional core support from the Lymphoma Research Trust. Individual projects are funded by competitive grants from Cancer Research UK, the Lymphoma Research Trust, the Medical Research Council, NIHR, and major pharmaceutical companies.

FOR ALL QUERIES PLEASE USE THE CONTACT TABS FOUND IN EACH OF THE INDIVIDUAL COURSES/CONFERENCES AND PRODUCTS, PLEASE ONLY CONTACT THE ONLINE STORE DIRECTLY IF YOU ARE EXPERIENCING PAYMENT DIFFICULTIES.

Cancer Research UK & UCL Cancer Trials Centre (H01)

Courses

H01 Cancer Treatments & Their Side Effects - Compliance & Adverse Event Reporting 130622

Description

This session is a basic introduction to common cancer treatments, such as surgery radiotherapy and chemotherapy and their most common side effects and adverse reactions.

Participants will learn about the reporting of treatment compliance and adverse events in cancer trial publications.

This course is not recommended for clinicians.

www.ctc.ucl.ac.uk

Attendee CategoryCost   
Attendees From For-Profit Organisations.£100.00[Read More]
Attendees From Non-Profit Organisations.£50.00[Read More]
Units Within ICTM.£0.00[Read More]
Courses

H01 Trial Outcomes 2022 - What Are We Trying To Measure

Description

This session, aimed at non statisticians, will cover the most common primary outcomes measures used in early and late phase cancer trials (response and time to event measures such as survial, disease free survival etc). Participants will learn what makes a good outcome measure, how outcomes measures are defined and what data need to be collected.

www.ctc.ucl.ac.uk

Attendee CategoryCost   
Attendees From For-Profit Organisations.£100.00[Read More]
Attendees From Non-Profit Organisations.£50.00[Read More]
Units Within ICTM.£0.00[Read More]

How would you rate your experience today?

How can we contact you?

What could we do better?

   Change Code